Journal of Lipid Research, Vol 30, 1197-1209, Copyright © 1989 by Lipid Research, Inc.

ARTICLES

Relationship of decreased hepatic lipase activity and lipoprotein abnormalities to essential fatty acid deficiency in cystic fibrosis patients

E Levy, G Lepage, M Bendayan, N Ronco, L Thibault, N Galeano, L Smith and CC Roy
Centre de Recherche Pediatrique, Hopital Ste-Justine, Montreal, Quebec, Canada.

Polyunsaturated fatty acids are known to affect plasma lipids and lipoproteins but there is no information on the effect of essential fatty acid (EFA) deficiency on lipoprotein composition. The purpose of this study was to characterize lipoproteins from 17 cystic fibrosis (CF) patients in relationship to their EFA status (eicosatrienoic/arachidonic acid ratio) and compare them with those of 10 healthy siblings (SIB) and of 10 unrelated controls. In 7 EFA- deficient (EFAD) and 10 EFA-sufficient (EFAS) patients, hypocholesterolemia was associated with a decrease of HDL-cholesterol and of LDL-cholesterol which was more marked in the EFAD group. Similarly, although triglyceride enrichment of VLDL, LDL, HDL2, and HDL3 with a concomitant reduction of cholesteryl esters from all particles except HDL2 was observed in both CF groups, it was more sizable in the EFAD patients. These changes led to an increase in the particle size of VLDL, LDL, and HDL2 whereas the distribution of HDL3 was skewed to smaller particles. Alterations in the apoprotein composition of particles were greater in EFAD than in EFAS. A decrease of total postheparin lipolytic activity was observed in the two groups of CF patients as well as in siblings. It was entirely accounted for by hepatic lipase (mumol FFA/ml per h) which was more severely diminished in EFAD (2.8 +/- 0.6) than in EFAS (4.4 +/- 0.7) and SIB (5.1 +/- 0.5). Although the two groups of CF children differed in terms of growth, severity of malabsorption, and vitamin E status, these data suggest that disturbance of lipoprotein concentration, composition, size, and metabolism (hepatic lipase) may be in part related to EFA deficiency. Further studies are necessary to explore the effect of EFA deficiency on hepatic lipase activity.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				N. Peretti, C. C. Roy, E. Drouin, E. Seidman, P. Brochu, G. Casimir, and E. Levy Abnormal intracellular lipid processing contributes to fat malabsorption in cystic fibrosis patients Am J Physiol Gastrointest Liver Physiol, April 1, 2006; 290(4): G609 - G615. [Abstract] [Full Text] [PDF]

				A. Werner, R. Havinga, T. Bos, V. W. Bloks, F. Kuipers, and H. J. Verkade Essential fatty acid deficiency in mice is associated with hepatic steatosis and secretion of large VLDL particles Am J Physiol Gastrointest Liver Physiol, June 1, 2005; 288(6): G1150 - G1158. [Abstract] [Full Text] [PDF]

				L. G. Wood, D. A. Fitzgerald, and M. L. Garg Hypothesis: Vitamin E Complements Polyunsaturated Fatty Acids in Essential Fatty Acid Deficiency in Cystic Fibrosis J. Am. Coll. Nutr., August 1, 2003; 22(4): 253 - 257. [Abstract] [Full Text] [PDF]

				A. Werner, D. M. Minich, R. Havinga, V. Bloks, H. Van Goor, F. Kuipers, and H. J. Verkade Fat malabsorption in essential fatty acid-deficient mice is not due to impaired bile formation Am J Physiol Gastrointest Liver Physiol, October 1, 2002; 283(4): G900 - G908. [Abstract] [Full Text] [PDF]

				L. Zhou and A. Nilsson Sources of eicosanoid precursor fatty acid pools in tissues J. Lipid Res., October 1, 2001; 42(10): 1521 - 1542. [Abstract] [Full Text] [PDF]

				F. N. Bhura-Bandali, M. Suh, S. F. P. Man, and M. T. Clandinin The {{Delta}}F508 Mutation in the Cystic Fibrosis Transmembrane Conductance Regulator Alters Control of Essential Fatty Acid Utilization in Epithelial Cells J. Nutr., December 1, 2000; 130(12): 2870 - 2875. [Abstract] [Full Text] [PDF]

				E. Levy, Y. Rizwan, L. Thibault, G. Lepage, S. Brunet, L. Bouthillier, and E. Seidman Altered lipid profile, lipoprotein composition, and oxidant and antioxidant status in pediatric Crohn disease Am. J. Clinical Nutrition, March 1, 2000; 71(3): 807 - 815. [Abstract] [Full Text] [PDF]

				J. H. Spalinger, E. G. Seidman, G. Lepage, D. Menard, V. Gavino, and E. Levy Uptake and metabolism of structured triglyceride by Caco-2 cells: reversal of essential fatty acid deficiency Am J Physiol Gastrointest Liver Physiol, October 1, 1998; 275(4): G652 - G659. [Abstract] [Full Text] [PDF]